Dow Chemical

Case Study: Dow Chemical

Why PharmaVentures?

Dow chose PharmaVentures because its track record in conducting auctions for pharmaceutical assets, completing sales in a timely manner and returning maximum value to its clients.

The Challenge

The Dow Chemical Company (Dow) engaged PharmaVentures to generate a transaction process and close a deal with the highest bidder for the opportunity.

The Solution

PharmaVentures conducted a thorough company screening and evaluation assessment to identify and prioritise potential acquirers with a good match for the technology and a strong strategic need in the relevant therapy area. Following the screening, within the space of a month PharmaVentures’ transaction team approached all the target companies with the value proposition using a non-confidential information package.

PharmaVentures managed the exchange of Confidential Disclosure Agreements followed by providing confidential information in a memorandum, supporting management presentations and managed access to the dataroom. Finally PharmaVentures provided negotiations support leading to the sale of Dow’s API manufacturing assets to Dr Reddy’s Laboratories.

The Pharma Product/ Technology/ Company Valuation

Case Study: The Pharma Product/ Technology/ Company Valuation

The Pharma Product/ Technology/ Company Valuation Challenge

A US specialist drug delivery company needed urgently to get a valuation of a potential acquisition candidate company. With its delivery technology the candidate company held a strong IP position in an undeveloped but emerging market area. The challenge was to understand fully the potential for the technology, find and evaluate benchmark comparable transactions to assist in the valuation and negotiation process.

The Solution

PharmaVentures undertook an in depth assessment of the drug delivery landscape to help position the underlying technology alongside competitors, and investigated the unique potential offered by the IP held by the target company.

A detailed search was then carried out using PharmaDeals Agreements® followed by a critical selection of the relevant benchmark deals using PharmaVentures extensive in-house expertise in drug delivery technologies and valuation criteria in this dynamic field.

The final valuation gave our client confidence about the acquired technologies’ potential and provided the expert basis for the deal negotiation.

Pharma Transactions, Deal Negotiations

Case Study: Pharma Transactions, Deal Negotiations

The Pharma Transactions Challenge

A large corporation planned to sell one of its key technology platforms and the compound originating from the Intellectual Property.

The client asked PharmaVentures to generate a pharma transaction process and close a deal with the highest bidder for the opportunity.

The Solution

PharmaVentures conducted a thorough company screening and evaluation assessment to identify and prioritise potential acquirers with a good match for the technology and a strong strategic need in the relevant therapy area. Following the screening, within the space of a month PharmaVentures’ transaction team approached all the target companies with the value proposition using a non-confidential information memorandum and the consultants thorough knowledge of the scientific area.

After the exchange of Confidential Disclosure Agreements this was followed by due diligence, technical communication and road show run by the transaction experts on behalf of the client company management. This process achieved several high bids and a final attractive transaction value within six months of start of the project.